Rosemary A. Underhill, MB., B.S., is a Physician Consultant and a Fellow of Royal College of Surgeons. Underhill trained as a physician, a surgeon and an obstetrician in London, England and was a medical student who witnessed the Royal Free Hospital outbreak in 1955.
Dr. Underhill is a consultant and member of the board of Trustees of the New Jersey ME/CFS Association.
2017 Pediatric Primer[edit | edit source]
Dr. Underhill was one of the authors of the 2017 Pediatric Primer published in Frontiers in Pediatrics.
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer by Peter C. Rowe, Rosemary A. Underhill, Kenneth J. Friedman, Alan Gurwitt, Marvin S. Medow, Malcolm S. Schwartz, Nigel Speight, Julian M. Stewart, Rosamund Vallings and Katherine S. Rowe(Full Text)
Books[edit | edit source]
- 2002, Dr. Underhill was on the writing committee for A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome, Joseph F. John, Jr., MD, Editor and James M. Oleske, MD, MPH, Associate Editor.
Hypothesis on the disease ME/CFS[edit | edit source]
Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease - Medical Hypotheses December 2015 Volume 85, Issue 6, Pages 765–773
Clinical guides[edit | edit source]
- Chronic Fatigue Syndrome/Myalgic Encephalomyelitis - Primer for Clinical Practitioners 2014 Edition IACFS/ME (Co-author.)
- A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome The Academy of Medicine of New Jersey and the New Jersey Department of Health and Senior Services. (Writing committee member.)
Articles[edit | edit source]
- 2006, Prevalence of Chronic Fatigue Syndrome and Chronic Fatigue Within Families of CFS Patients
Open letter to The Lancet[edit | edit source]
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Underhill, along with 41 colleagues in the ME/CFS field, signed the second letter.
- 10 February 2016, An open letter to The Lancet, again - Virology blog
CFSAC testimony[edit | edit source]
- October 2012 Public Comment to CFSAC - "Suggested protocol for investigating cluster outbreaks of ME/CFS"
See also[edit | edit source]
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer
- Open letter to the Lancet
- New Jersey ME/CFS Association
References[edit | edit source]
- Rosemary Underhill - Zoom Information
- Rowe, Peter C.; Underhill, Rosemary A.; Friedman, Kenneth J.; Gurwitt, Alan; Medow, Marvin S.; Schwartz, Malcolm S.; Speight, Nigel; Stewart, Julian M.; Vallings, Rosamund; Rowe, Katherine S. (2017), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer", Frontiers in Pediatrics, 5 (121), doi:10.3389/fped.2017.00121
- Oleske JJ. A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome. The Academy of Medicine of New Jersey, The New Jersey Department of Health & Senior Services; 2002.
- Rosemary A. Underhill & Ruth O'Gorman. (2006). Prevalence of Chronic Fatigue Syndrome and Chronic Fatigue Within Families of CFS Patients. Journal of Chronic Fatigue Syndrome, Vol. 13, Iss. 1, pp. 3-13. http://dx.doi.org/10.1300/J092v13n01_02
Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.
Chronic fatigue syndrome advisory committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.